Found: 17
Select item for more details and to access through your institution.
Phase I study of resminostat, an HDAC inhibitor, combined with S-1 in patients with pre-treated biliary tract or pancreatic cancer.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 1, p. 109, doi. 10.1007/s10637-018-0634-5
- By:
- Publication type:
- Article
Plasmapheresis therapy has no triglyceride-lowering effect in patients with hypertriglyceridemic pancreatitis.
- Published in:
- 2017
- By:
- Publication type:
- letter
Prognostic Factors for Survival in Patients with Advanced Intrahepatic Cholangiocarcinoma Treated with Gemcitabine plus Cisplatin as First-Line Treatment.
- Published in:
- Oncology, 2018, v. 94, n. 2, p. 72, doi. 10.1159/000480703
- By:
- Publication type:
- Article
A phase II study of FOLFIRINOX with primary prophylactic pegfilgrastim for chemotherapy-naïve Japanese patients with metastatic pancreatic cancer.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 11, p. 2065, doi. 10.1007/s10147-021-02001-y
- By:
- Publication type:
- Article
Multicenter Phase II Trial of Axitinib Monotherapy for Gemcitabine‐Based Chemotherapy Refractory Advanced Biliary Tract Cancer (AX‐BC Study).
- Published in:
- Oncologist, 2021, v. 26, n. 2, p. 97, doi. 10.1002/onco.13547
- By:
- Publication type:
- Article
Alternate Endpoints for Phase II Trials in Advanced Neuroendocrine Tumors.
- Published in:
- Oncologist, 2019, v. 24, n. 1, p. 47, doi. 10.1634/theoncologist.2017-0651
- By:
- Publication type:
- Article
The "histological replacement growth pattern" represents aggressive invasive behavior in liver metastasis from pancreatic cancer.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 9, p. 3130, doi. 10.1002/cam4.2954
- By:
- Publication type:
- Article
Impact of Endoscopic Ultrasound-Guided Tissue Acquisition on Decision-Making in Precision Medicine for Pancreatic Cancer: Beyond Diagnosis.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 7, p. 1195, doi. 10.3390/diagnostics11071195
- By:
- Publication type:
- Article
Case Report: Atezolizumab plus bevacizumab for combined hepatocellular-cholangiocarcinoma.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1234113
- By:
- Publication type:
- Article
Endoscopic Ultrasound-Guided Gallbladder Drainage for Aberrant Right Posterior Duct Obstruction Developing after Placement of a Covered Self-Expandable Metallic Stent in a Patient with Distal Biliary Obstruction.
- Published in:
- Case Reports in Gastroenterology, 2018, v. 12, n. 3, p. 722, doi. 10.1159/000492215
- By:
- Publication type:
- Article
Correction: Palliative radiotherapy for tumor bleeding in patients with unresectable pancreatic cancer: a single-center retrospective study.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Palliative radiotherapy for tumor bleeding in patients with unresectable pancreatic cancer: a single-center retrospective study.
- Published in:
- Radiation Oncology, 2023, v. 18, n. 1, p. 1, doi. 10.1186/s13014-023-02367-5
- By:
- Publication type:
- Article
Efficacy of radiotherapy for primary tumor in patients with unresectable pancreatic neuroendocrine tumors.
- Published in:
- Japanese Journal of Clinical Oncology, 2017, v. 47, n. 9, p. 826, doi. 10.1093/jjco/hyx081
- By:
- Publication type:
- Article
Chemotherapy-induced neutropenia as a prognostic factor in patients with pancreatic cancer treated with gemcitabine plus nab-paclitaxel: a retrospective cohort study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
New Era of Endoscopic Ultrasound-Guided Tissue Acquisition: Next-Generation Sequencing by Endoscopic Ultrasound-Guided Sampling for Pancreatic Cancer.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 8, p. 1173, doi. 10.3390/jcm8081173
- By:
- Publication type:
- Article
Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Fibroblast inhibition by tocilizumab enabled gemcitabine/nab‐paclitaxel rechallenge for pancreatic cancer.
- Published in:
- Cancer Science, 2023, v. 114, n. 10, p. 4006, doi. 10.1111/cas.15929
- By:
- Publication type:
- Article